Jun 11 2007, 8:00 AM EST
News source: Business Wire
King Pharmaceuticals, Inc. (NYSE:KG) announced today that it is the 11th pharmaceutical company to join Together Rx Access,(TM) a prescription savings program created by leading pharmaceutical companies to help individuals and families gain access to meaningful savings on prescription medicines.
"We are extremely pleased to welcome King Pharmaceuticals as a new member company and commend its commitment to helping Americans without prescription drug coverage gain access and savings," said Roba Whiteley, executive director of Together Rx Access. "The Together Rx Access(TM) Program continues to gain momentum, enrolling nearly 10,000 Americans each week."
An estimated 47 million Americans, including nine million children, do not have healthcare coverage. The uninsured population includes two-income families, single parents, the self-employed, recent college graduates, and low-wage workers, among others. In fact, eight out of 10 uninsured people are in families where one or more members are employed.
"We are proud to participate in the Together Rx Access Program, which offers immediate help to eligible individuals and their families, and has proven it can make a real difference," said Brian A. Markison, Chairman and CEO of King Pharmaceuticals, Inc. "This program is a great example of our industry recognizing and responding to a public need by coming together to develop and participate in an innovative and effective solution."
"The participation of King Pharmaceuticals enhances the Together Rx Access Program's value to cardholders by expanding the number of brand-name prescription medicines in the Program, including those to treat many common conditions such as hypertension, hypothyroidism and chronic pain," added Whiteley.
King's participation in the Together Rx Access Program will provide cardholders with savings on products such as Altace(R) (ramipril); Skelaxin(R) (metaxalone); Avinza(R)(morphine sulfate extended release); Sonata(R) (zaleplon); and Levoxyl(R) (levothyroxine sodium tablets, USP).
King Pharmaceuticals joins the following companies already participating in the Together Rx Access Program: Abbott Laboratories; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; GlaxoSmithKline; Janssen, L.P.; Johnson & Johnson Wound Management, a Division of ETHICON, Inc.; LifeScan, Inc.; McNeil Pediatrics, a Division of McNeil-PPC, Inc.; Novartis Pharmaceuticals Corporation; Ortho Biotech Products, L.P.; Ortho-McNeil, Inc.; Ortho-McNeil Neurologics, Inc.; OrthoNeutrogena, a Division of Ortho-McNeil Pharmaceutical, Inc.; Ortho Women's Health & Urology, a Division of Ortho-McNeil Pharmaceutical, Inc.; Pfizer Inc; PriCara, a Unit of Ortho-McNeil, Inc.; sanofi-aventis U.S. LLC.; Takeda Pharmaceuticals North America, Inc.; TAP Pharmaceutical Products Inc.; Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P.; and Vistakon Pharmaceuticals, LLC.
About King Pharmaceuticals, Inc.
King Pharmaceuticals, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.
About Together Rx Access
The Together Rx Access Card was created by leading pharmaceutical companies to help hardworking Americans and their families gain access to meaningful savings on prescriptions right at their neighborhood pharmacy. Most cardholders save 25 to 40 percent(1) on brand-name prescription products, including me
ADVERTISEMENT
INTERVIEW:
(BIO) BANKING IN LUXEMBOURG - Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.)
...MORE
NewsArticles Blogs| Most Viewed | Most Emailed | Top Searches |
|---|---|---|
| Unclog the Innovation Bottleneck at our Nation’s Universities | ||
| (Bio) Banking in Luxembourg | ||
ADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All